Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study.
Juan F Sánchez Muñoz-TorreroGuillermo Escudero-SánchezJulián F Calderón-GarcíaSergio Rico-MartinNicolás Roberto RoblesM Asunción BacaicoaJosé N Alcalá-PedrajasGuadalupe Gil-FernándezManuel Monrealnull On Behalf Of The Frena InvestigatorsPublished in: International journal of environmental research and public health (2021)
In this real-world cohort of symptomatic arterial disease patients, most of whom are not eligible for clinical trials, the risk of subsequent events and death varies according to the levels of SBP and the location of previous events. Especially among patients with large artery atherosclerosis, PAD or CVD, SBP <130 mm Hg may result in increased mortality. Due to potential factors in this issue, Prospective, well designed studies are warranted to confirm these observational data.
Keyphrases
- blood pressure
- clinical trial
- end stage renal disease
- ejection fraction
- chronic kidney disease
- heart failure
- newly diagnosed
- cardiovascular disease
- left ventricular
- peritoneal dialysis
- cardiovascular events
- electronic health record
- hypertensive patients
- machine learning
- adipose tissue
- cross sectional
- fluorescent probe
- metabolic syndrome
- climate change
- randomized controlled trial
- big data
- coronary artery disease
- open label
- data analysis
- atrial fibrillation
- glycemic control
- patient reported
- study protocol
- living cells